|Slideshows|October 3, 2019

8 examples of how GBCA improves MRI

Author(s)Ilana Cass, MD, Rola Saouaf, MD

Gadolinium-based intravenous contrast agents (GBCA) provide additional information based on signal intensity changes after GBCA administration.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

ByJustin Drake, PhD

June 4th 2026

Willow announces new breastfeeding accessories to support postpartum care

ByJoshua Fitch, Senior Editor

March 24th 2026

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

ByJoshua Fitch, Senior Editor

January 26th 2026

Breastfeeding and later maternal depression and anxiety with Fionnuala McAuliffe

ByFionnuala McAuliffe MD, FRCOG, FRCPI, FSEM, FACOG, FICOG

January 23rd 2026

Low-dose megestrol enhances anti-oestrogen therapy in breast cancer

ByCeleste Krewson, Assistant Editor

January 12th 2026

Latest CME

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

8 examples of how GBCA improves MRI

Related Content

Justin Drake, PhD, explains the Certitude Breast blood test for early breast cancer detection

Willow announces new breastfeeding accessories to support postpartum care

Aviva to advance, announce new data for AVA-291 women's testosterone therapy

Breastfeeding and later maternal depression and anxiety with Fionnuala McAuliffe

Low-dose megestrol enhances anti-oestrogen therapy in breast cancer

Latest CME

Join Us at The Pathology Meeting in Las Vegas

Join Us at The Pathology Meeting in Las Vegas

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

FDA working with manufacturers to increase access to estradiol transdermal patches

Kevin Ault, MD, on the maternal and fetal benefits of COVID-19 and flu vaccination in pregnancy

ACOG's 2026-27 respiratory virus immunization recommendations in pregnancy, postpartum

Kevin Ault, MD, on the extended RSV window in ACOG's 2026-27 immunization guidance

David Shalowitz, MD, on strengthened evidence behind salpingectomy for ovarian cancer prevention